Table 2.
Total intensive care unit costs with dexmedetomidine and current standard care sedatives, expressed as euros per patient
| Mean (SD) | Difference in means, € | Median (IQR) | Difference in medians, € | |||
|---|---|---|---|---|---|---|
| Dexmedetomidine | Standard care | Dexmedetomidine | Standard care | |||
| Pooled | 19,609 (19,568) | 21,258 (19,298) | −1,649 | 11,864 (7,070-23,457) | 14,520 (7,871-26,254) | −2,656 |
| MIDEX | 20,342 (19,412) | 22,878 (19,483) | −2,536 | 12,871(8,126-25,147) | 16,444 (8,955-27,676) | −3,573 |
| PRODEX | 18,872 (19,735) | 19,619 (19,008) | −747 | 11,016 (6,781-21,696) | 12,308 (6,787-25,247) | −1,292 |
In MIDEX, the standard care sedative was midazolam; in PRODEX, it was propofol. IQR, interquartile range; SD, standard deviation.